Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
16.75
-0.33 (-1.93%)
At close: Oct 21, 2025, 4:00 PM EDT
16.75
0.00 (0.00%)
After-hours: Oct 21, 2025, 4:10 PM EDT

Dyne Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
2,3832,398816604606954
Upgrade
Market Cap Growth
-29.26%193.72%35.12%-0.32%-36.50%-
Upgrade
Enterprise Value
1,8231,699687387233585
Upgrade
Last Close Price
17.0823.5613.3011.5911.8921.00
Upgrade
PB Ratio
3.423.818.942.391.652.79
Upgrade
P/TBV Ratio
4.173.818.942.391.652.79
Upgrade
Debt / Equity Ratio
0.210.040.300.120.09-
Upgrade
Quick Ratio
16.4915.202.419.1213.1131.49
Upgrade
Current Ratio
16.8315.602.539.4613.3131.83
Upgrade
Return on Equity (ROE)
-61.32%-88.03%-137.31%-54.18%-42.02%-33.35%
Upgrade
Return on Assets (ROA)
-35.45%-50.20%-64.21%-29.20%-24.07%-19.82%
Upgrade
Return on Capital (ROIC)
-36.91%-55.64%-75.38%-31.26%-25.23%-20.57%
Upgrade
Earnings Yield
-17.31%-13.24%-28.90%-27.82%-24.63%-6.23%
Upgrade
FCF Yield
-15.17%-12.29%-23.14%-25.94%-20.33%-5.00%
Upgrade
Buyback Yield / Dilution
-44.14%-57.74%-14.83%-2.13%-253.54%-489.30%
Upgrade
Updated Jul 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q